The Effectiveness of Mindfulness-based Intervention on Smoking Cessation
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03480113 |
|
Recruitment Status : Unknown
Verified May 2018 by Yeh, Chung Shan Medical University.
Recruitment status was: Recruiting
First Posted : March 29, 2018
Last Update Posted : May 18, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Smoking Cessation | Behavioral: Mindfulness-based Intervention Behavioral: Physical fitness intervention | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 100 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | A Pilot Study of the Effectiveness of Mindfulness-based Intervention on Smoking Cessation: a Workplace Health-promoting Program |
| Actual Study Start Date : | March 16, 2018 |
| Estimated Primary Completion Date : | December 2018 |
| Estimated Study Completion Date : | December 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Mindfulness-based Intervention
1 session of health education regrading the harms from smoking and 6 sessions of Mindfulness-based intervention, 1 hour each session.
|
Behavioral: Mindfulness-based Intervention
mindful breath, body scan, sitting meditation and walking meditation and so on. |
|
Active Comparator: Physical Fitness intervention
1 session of health education regrading the harms from smoking and 6 sessions of physical fitness and stretch exercise, 1 hour each session.
|
Behavioral: Physical fitness intervention
giving the lessons of stretch exercise, aerobics to strength muscle and lung fuctions. |
- Nicotine dependence level [ Time Frame: Up to 8 months ]Fagerstrom Dependence Questionnaire was adopted to assess the level of Nicotine dependence
- Self-reported stress [ Time Frame: Up to 8 months ]10 items of Perceived Stress Scale was adopted to assess the level of perceived stress. This scale uses the Likert five-point scoring method, from 0-4. The higher scores indicate higher pressure levels.
- Psychological distress [ Time Frame: Up to 8 months ]Psychological distress was measured by the Chinese Health Questionnaire (CHQ-12), a well-validated instrument. A total of 12 items using the Likert four-point scoring method, with scores ranged from 0-36. The higher scores indicates higher level of psychological distress.
- the Level of mindfulness [ Time Frame: Up to 8 months ]Measuring the level of Mindfulness, using the Likert five-point scoring method, a total of 39 questions, including the five concepts, namely: awareness (8 questions), description (8 questions), non-judging (8 questions), observation (8 questions), and non-reaction (7 questions). The higher scores indicate higher levels of mindfulness.
- the level of CO [ Time Frame: Up to 8 months ]The Smokerlyzer was adopted to assess the participants' CO level. <5ppm indicates nonsmoker; 5~7ppm indicates lighter smokers; ≧8ppm indicates heavy smokers.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 20 Years to 65 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- volunteered employees with heavy smoker
- Full-time paid workers
Exclusion Criteria:
- Age < 20y or > 65y
- Part-time workers
- The workers are not willing to take part in the study
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03480113
| Contact: Shu-Ling Huang, PhD | +886-4-24730022 ext 12301 | shuling@csmu.edu.tw |
| Taiwan | |
| AIDC | Recruiting |
| Taichung, Taiwan, 433 | |
| Contact: Lingyi Wang, RN | |
| Principal Investigator: Lingyi Wang, RN | |
| Principal Investigator: | Shu-Ling Huang, PhD | Department of Psychology, Chung Shan Medical University |
| Responsible Party: | Yeh, professor, Chung Shan Medical University |
| ClinicalTrials.gov Identifier: | NCT03480113 |
| Other Study ID Numbers: |
CS16175 |
| First Posted: | March 29, 2018 Key Record Dates |
| Last Update Posted: | May 18, 2018 |
| Last Verified: | May 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |

